A proof-of-concept study poised to remodel the drug development process: Liver-Chip solutions for lead optimization and predictive toxicology

Front Med Technol. 2022 Dec 16:4:1053588. doi: 10.3389/fmedt.2022.1053588. eCollection 2022.
No abstract available

Keywords: FDA regulations; animal testing; drug development; drug-Induced liver toxicity (DILI); liver-chip; microphysiological systems (MPS); organ-chip; predictive toxicology.